Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes

Prostaglandins

Volumn 54, Issue 2, 1997, Pages 511-530

  Li, Yunyuan ^a   Kang, Jing X ^a   Leaf, Alexander ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arrhythmia; Eicosanoids; Myocytes; Neonatal; Rat

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANTIARRHYTHMIC AGENT; ARACHIDONIC ACID DERIVATIVE; ICOSANOID; ISOPRENALINE; LEUKOTRIENE B4; LEUKOTRIENE B5; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LIPOXYGENASE; OUABAIN; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F3 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2;

ANIMAL CELL; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; HEART ARRHYTHMIA; HEART CONTRACTION; HEART MUSCLE CELL; MUSCLE FIBER CONTRACTION; NEWBORN; NONHUMAN; RAT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACID; ARRHYTHMIA; CELLS, CULTURED; DINOPROST; DINOPROSTONE; EICOSANOIDS; EICOSAPENTAENOIC ACID; EPOPROSTENOL; HEART; HEART RATE; LIPOXYGENASE; MYOCARDIAL CONTRACTION; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2;

EID: 0030810828     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(97)00122-6     Document Type: Article

References (24)

1. Parratt J.R., Wainwright C.L., Coker S.J., Zeitlin I.J. Eicosanoids and cardiac arrhythmias. Biomed. Biochim. Acta. 47:1988;s13.
2. Curtis M.J., Pugsley M.K., Walker M.J.A. Endogenous chemical mediators of ventricular arrhythiias in ischemic heart disease. Cardiovasc. Res. 27:1993;703.
3. Parratt J. Endogenous myocardial protective (antiarrhythmic) substances. Cardiovas. Res. 27:1993;693.
4. Charnock J.S. Lipids and cardiac arrhythmia. Prog. Lipid Res. 33:1994;355.
5. Coker S.J., Parratt J.R., Ledingham I.M., Zeitlin I.J. Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium. J. Mol. Cell Cardiol. 14:1982;483.
6. Johnston K.M., MacLeod B.A., Walker M.J.A. Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br. J. Pharmacol. 78:1983;29.
7. Martinez T.T., Crampton J.M. Prostaglandins show marked differences when tested against early ischemic dysrhythmias in rat. Life Science. 29:1981;1449.
8. 2 on arrhythmias produced by coronary occlusion in the rat and dog. Prostaglandins. 18:1979;707.
9. Kang J.X., Leaf A. Effects of long-chain, polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA. 91:1994;9886.
10. Kang J.X., Leaf A. Protective effects of all-trans retinoic acid on arrhythmias induced by lysophosphotidylcholine, isopretenol or ischemia and reperfusion. J. Cardiovas. Pharmacol. 26:1995;943.
11. Kang J.X., Leaf A. Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem. Biophy. Res. Comm. 208:1995;629.
12. Kang J.X., Leaf A. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphotidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Europ. J. Pharmacol. 297:1996;97.
13. Thandroyen F.T., Morris A.C., Hagler B.et al. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ. Res. 69:1991;810.
14. Barry W.H., Smith T.W. Movement of calcium across the sarcolemma, effects of abrupt exposure to zero external sodium concentrations. J. Mol. Cell Cardiol. 16:1984;155.
15. Kang J.X., Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids:recent studies. Circulation. 94:1996;1774.
16. Oudot F., Grynberg A., Sergiel JP Eicosandoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am. J. Physiol. 268:1995;H308.
17. Negishi m., Sugimoto Y., Ichikawa A. Prostanoid receptors and their biological actions. Prog. Lipid Res. 32:1993;417.
18. Kang J.X., Xiao Y.F., Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA. 92:1995;3997.
19. Xiao Y.F., Kang J.X., Morgan J.P., Leaf A. Blocking effects of polyunsaturated fatty acids on sodium currents of neonatal rat cardiacmyocytes. Proc. Natl. Acad. Sci. USA. 92:1995;11000.
20. Zijlstra W.G., Brunsting J.R., Hoor F.T., Vergroesen Prostaglandin E1 and cardiac arrhythmia. Europ. J. Pharmacol. 18:1972;392.
21. Kobayashi T., Nakayama R., Kimura K. Effects of glucagon, prostaglandin E1 and dibutyryl cyclic 3′,5′-AMP upon the transmembrane action potential of guinea pig ventricular fiber and myocardial contractile force. Jap. Cir. J. 35:1971;807.
22. Kecskemeti V., Kelemen K., Knoll J. Effect of prostaglandin E1 on the cardiac transmembrane potentials. Europ. J. Pharmacol. 24:1973;289.
23. Tobias L.D., Hamilton J.G. The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism. Lipids. 14:1978;181.
24. Stainier D.Y.R., Fouquet B., Chen J.et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 123:1996;285.